Clinical Trial

A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults

Name: A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults — clinical trial record (NCT07749651)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Trial Details

NCT Number	NCT07749651
Lead Sponsor	Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions	Cutaneous Lupus Erythematosus(CLE)
Enrollment	50 participants
Start Date	2026-08
Primary Completion	2027-04 (estimated)
Study Completion	2027-08 (estimated)
Updated on ClinicalTrials.gov	2026-08-06